Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures

NCT01370044 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT01370044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01370044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 2/3
Overall status
Terminated
Start date
August 31, 2012
Completion date
June 30, 2015
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

febrile seizure